Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Combining low-level light therapy and minoxidil 5% is more effective for female hair loss than using either treatment alone.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Stress and alcohol affect brain chemicals differently in rats, mice, and humans, influenced by genetic differences.

Most dogs with alopecia had higher than normal levels of certain hormones, but hair loss might not always be linked to these hormone changes.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Large prostate links to more hair loss, but age of onset doesn't affect it.

In Brazil in 2018, the most common skin issues were acne, photoaging, and nonmelanoma skin cancer, with treatments often including topical medications and sunscreen.

KFSD is a genetic disorder causing hair loss and skin issues, with no effective treatment.

Using finasteride with TIP extends time off period for prostate cancer patients.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

WAA-QOL measures impact of hair loss on women's well-being.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Hair loss in women links to inflammation around hair follicles.

Hair thickness differences help diagnose hair loss severity.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Most hair loss in captive rhesus macaques is likely due to environmental and behavioral factors.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

The normal human prostate does not significantly affect blood DHT levels.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

Three specific proteins can turn adult skin cells into hair-growing cells, suggesting a new hair loss treatment.

Every elderly patient had at least one skin condition, often linked to other diseases, highlighting the need for integrated skin and general healthcare in the elderly.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

In situ DNA labeling in hair can help predict forensic DNA analysis success.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.